Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.52 |
| ▸ | NMT1 | P30419 | 4/20 | 0.52 |
| ▸ | NMT2 | O60551 | 3/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | FNTA | P49354 | 1/20 | 0.45 |
| ▸ | FNTB | P49356 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7034266 | 1.00 | SLC6A5 (0.62) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL16927658 | 0.87 | SLC6A5 (0.72) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL7027662 | 0.87 | SLC6A5 (0.72) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL7027659 | 0.87 | SLC6A5 (0.72) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL3496665 | 0.87 | SLC6A5 (0.72) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL3496668 | 0.87 | SLC6A5 (0.72) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL11206719 | 0.86 | SLC6A5 (0.67) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL9634093 | 0.86 | SLC6A5 (0.67) | SLC6A5NOD1NMT1NMT2FOLH1 | |
| SCHEMBL9635202 | 0.83 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1EPHX2 | |
| SCHEMBL9716743 | 0.83 | SLC6A5 (0.85) | SLC6A5NOD1FOLH1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0822827-B1 | ANTAGONISTS OF LHRH | UNIV TEXAS (US) | 2003-03-05 | — | — | EP | disclosed |